SARS-CoV-2 (COVID-19) Nucleocapsid Recombinant protein

• Background:

  A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

• Tag:

  His Tag

• Type:

  Recombinant Proteins

• Source:

  E. coli

• Field of Research:

  Infectious Disease, COVID-19

• Purity:

  >95% pure as determined SDS-PAGE.

• Buffer:

  CoV 2019 protein solution is supplied in PBS and 10mM K2CO3.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  Store in working aliquots at -20˚ C. Avoid freeze/thaw cycles.

• Species:

  SARS-CoV-2

• Physical Properties:

  Liquid

• CAS Number:

  9000-83-3